No description available.

Μελετήσαμε την δράση της ακτινοβολίας στο εντερικό επιθήλιοκαι αν η χορήγηση αυξητικής ορμόνης και IGF-I μπορεί να αναστρέψει αυτήν την δράση.Συμπερασματικά η ακτινοβολία προκαλεί ατροφία και εξέλκωση του επιθηλίου και διαταραχή του εντερικού φραγμού μέσω επαγωγής της απόπτωσης των κυττάρων του εντερικού επιθηλίου και οδηγεί σε ατροφία, εξελκώσεις και διαταραχή της λειτουργικής ακεραιότητας του εντέρου ενώ η χορήγηση GH ή IGF-I αναστέλλει την απόπτωση των κυττάρων και διατηρεί την ακεραιότητα του εντερικού επιθηλίου. / We studied the effect of growth hormone (GH) and insulin-like growth factor-I (IGF-I) on intestinal mucosal integrity and bacterial translocalion after abdominal radiation in rats.We have shown that abdominal radiation causes intestinal epithelial cell damage mainly through the induction of apoptosis and the treatment with GH and IGF-I inhibits apoptosis of the cells and preserves the mucosal integrity and also reduce the bacterial translocation that follows intestinal radiation.

<p>Transferrin receptor 1 (Tfr1) serves as a receptor for transferrin, an iron-binding protein in the blood, in its canonical role of iron assimilation. Tfr1 is expressed ubiquitously in many tissues and is believed to be required for iron uptake by most cells. </p><p>The Tfr1 global knockout mouse highlights the requirement for Tfr1 in erythrocyte precursors. The erythron is the tissue with the highest iron requirement, to enable hemoglobin production. Tfr1-null embryos die by embryonic day 12.5 with anemia, which has been assumed to cause lethality of the knockout mice. Due to the embryonic lethality of the mice, the role of Tfr1 has not been well characterized in other tissues in vivo. This thesis examines the role of Tfr1 in other tissues through the generation and characterization of conditional knockout mouse models of Tfr1 deletion in the intestinal epithelium, pancreas, and skin.</p><p>Tfr1 is expressed on the basolateral surface of proliferating cells in the intestinal epithelium. Deletion of Tfr1 specifically in the intestinal epithelium resulted in the loss of intestinal epithelial homeostasis, loss of proliferation, lipid accumulation, gene expression indicating epithelial to mesenchymal transition of intestinal epithelial cells, and early neonatal lethality. These phenotypes were mostly alleviated by forced expression of a mutant Tfr1 allele which is unable to bind to iron-loaded transferrin, suggesting that Tfr1 has a novel role independent of its canonical iron-assimilatory ability.</p><p>Deletion of Tfr1 in the pancreas resulted in juvenile death due to perturbed homeostasis of both endocrine and exocrine tissues, resulting in symptoms associated with pancreatitis and diabetes. No diabetic phenotype was detected in the conditional knockout mouse model of Tfr1 deletion specifically in &#946;-cells, suggesting that the primary effect of the loss of Tfr1 was limited to the exocrine tissue.</p><p>Deletion of Tfr1 in the epidermis of the skin caused neonatal lethality with abnormal hair follicle morphology and a significant reduction in dermal adipocytes.</p><p>These results indicate that the loss of Tfr1 has pleiotropic effects, depending on the cell type affected. Furthermore, Tfr1 appears to have non-canonical functions in the intestinal epithelium, a novel discovery.</p> / Dissertation

This study was conducted to determine if electroporation could deliver membrane-impermeant molecules intracellularly to intact, physiologically competent monolayers that mimic the intestinal epithelium. The long-term effects of electroporation on these monolayers were studied to determine the kinetics with which monolayers recover barrier function. The ability of electroporation to introduce biologically active molecules, e.g., plasmid DNA and siRNA, into these monolayers, to either express a protein of interest or modify cellular function, was also studied. Results showed that intracellular uptake of calcein, a small tracer molecule, and bovine serum albumin, a globular protein, occurred uniformly throughout the monolayers and increased as a function of voltage, pulse length, and pulse number. There was no significant difference in uptake resulting from single and multiple pulses of the same total exposure time. Barrier function recovery depended on the electroporation conditions applied, with some monolayers recovering normal physiologic function within a day. Electroporation also increased the permeability of the monolayers to calcein and BSA, possibly through a combination of increased paracellular and transmonolayer transport. When compared to cationic lipid transfection (lipofection), transfection of intestinal epithelial monolayers with reporter plasmids by electroporation was more efficient in situations where high concentrations of DNA, and as a result, higher levels of expression were needed. Although uptake of DNA was high after electroporation and increased with increasing amounts of DNA, overall expreseion efficiency was still low (~3%). Electroporation-mediated transfection of intestinal epithelial monolayers with a plasmid that expressed inflammation inhibitor protein, IκВα was not always successful, probably because of low levels of protein expression. Introduction of the much smaller siRNA molecules into the monolayers by electroporation, on the other hand, was very successful at inhibiting the production of the nuclear envelope proteins lamin A and lamin C. The results of these experiments demonstrated that electroporation can introduce a wide variety of molecules intracellularly into model intestinal epithelia. These results should be useful to identify optimal electroporation conditions for transporting drugs, proteins, and genes into intestinal and, possibly, other epithelia for local drug and gene therapy, as well as for development of improved models of intestinal epithelium.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20804号 / 医博第4304号 / 新制||医||1025(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 河本 宏, 教授 松田 文彦, 教授 柳田 素子 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Des pathologies lourdes, telles que les dystrophies de la rétine et certains cancers, impliquent une désorganisation de l'épithélium et la famille Crb, dont la protéine apicale Crumbs3 (isoformes Crb3A et Crb3B) fait partie. Les protéines transmembranaires Crb possèdent un domaine intracellulaire fortement conservé et des partenaires communs. Il est donc essentiel de comprendre comment ces protéines Crb sont régulées afin de mieux appréhender ces pathologies. Pour cela, j'ai étudié le complexe de polarité apical Crb3A (Crb3A, Pals1, PATJ) impliqué dans l'établissement et le maintien de la polarité apico-basale. Je me suis, tout d'abord, intéressée à la régulation des isoformes de Crb3 par leurs partenaires (Pals1 et PATJ), puis, à la régulation des protéines de la membrane apicale, dont Crb3A, par la Drebrine E2, un nouveau partenaire de Crb3A impliqué dans l'organisation du cytosquelette d'actine et la morphogenèse apicale. Mon travail a permis de mettre en évidence: 1) la régulation de la dynamique membranaire des isoformes de Crb3 par PATJ dans les cellules Caco-2/TC7, une lignée épithéliale intestinale humaine, mais aussi, 2) d'identifier une nouvelle fonction de la Drebrine E2 dans la régulation du trafic de plusieurs protéines de la membrane apicale dans ces cellules, dont, par exemple, la DPPIV (DiPeptidyl Peptidase IV). Dans les cellules déplétées en Drebrine E2, l'expression des protéines apicales est diminuée et leur endocytose est augmentée, puis, elles sont relocalisées dans le compartiment majeur de dégradation, le lysosome. / Some serious diseases like retinal dystrophies and some cancers involve epithelial cells disorganization and the Crumbs (Crb) proteins family. The apical Crb3 (Crb3A and Cr3B isoforms) protein belongs to Crb family. The transmembrane proteins Crb have a conserved intracellular domain with common partners. It is unclear how Crb proteins are regulated by their partners and this information is required to better understand these pathologies. Here, we decided to study the apical polarity Crb3A complex (Crb3A, Pals1, PATJ) which is involved in apico-basal polarity establishment and maintenance. First, I investigated Crb3 isoforms regulation by their partners (Pals1 and PATJ). Then, I studied the regulation of apical membrane proteins, such as Crb3A, by Drebrin E2, a new partner of Crb3A which is involved in actin cytoskeleton remodeling and apical morphogenesis. During my thesis, I demonstrated: 1) the regulation of Crb3 isoforms dynamics by PATJ in Caco-2/TC7 human intestinal epithelial cells, but also, 2) a new function for Drebrin E2 in regulating the trafficking of apical membrane proteins, like DPPIV (DiPeptidyl Peptidase IV). In Drebrin E2 KD cells, apical membrane proteins expression is decreased and we observe an increased endocytosis. This leads to relocalization of the apical membrane proteins to the main degradative compartment, the lysosome. These new datas suggest a role for Drebrin E2 in the regulation of apical membrane proteins recycling pathway. The Drebrin E2 KD cells phenotype is reminiscent of the microvillar inclusions disease (MVID). Now, I am trying to investigate the link between theses pathways.

The plot of this PhD thesis is dedicated to investigation of the molecular pathways and events and their disruptions in the gastrointestinal tract (further abbreviated as GIT). The major role in this part plays the Wnt signaling pathway. This marvelous multipurpose machinery is responsible for epithelia renewal from stem cells (SCs) in the stomach and intestine, and for correct zonation and function of hepatic units. Of note, the Wnt pathway directs also development of embryo as well as homeostasis of many tissues apart from GIT in all metazoans, thus its flawless function is indispensable from one's origin to death. The main part of the thesis follows canonical Wnt signaling in its physiological condition and, in contrast, with pathological disturbances. This issue can be taken by variety of means as it is described in attached publications. The first publication deals with searching for new participants of Wnt signaling and their functions and describing unique markers of SCs in the intestine. Troy, the member of tumor necrosis factor receptor (TNFR) superfamily, was identified as a novel marker of intestinal SCs by probing microarray data from chromatin immunoprecipitation obtained in cultured colorectal cancer cell lines. Moreover, we found that Troy is a Wnt target gene inhibiting the...

Este trabalho teve como objetivo propor novo método para estudar a permeabilidade de fármacos, utilizando epitélio intestinal de rã-touro (Rana catesbeiana) em método ex vivo, empregando células de Franz. Por utilizar epitélio intestinal, um material de descarte proveniente de um animal utilizado como alimento humano, pode ser considerado um método alternativo, pois não implica no sacrifício de animais. A quantidade de fármaco permeada foi determinada por método de eletroforese capilar com detecção ultravioleta e validado para os antivirais lamivudina, zidovudina e aciclovir, na presença de metoprolol e floridizina. O fármaco escolhido como modelo nos ensaios de permeabilidade foi a lamivudina. Para estabelecimento do protocolo experimental dos estudos de permeabilidade, foi proposta uma análise de variância three-way para verificar a influência na permeabilidade dos fármacos, das seguintes variáveis: secção intestinal, pH da solução de Ringer e temperatura. Foram determinados a quantidade total de fármaco permeado (Qt), o coeficiente de permeabilidade aparente (Papp) e a constante de absorção de primeira ordem (ka). A partir da análise do planejamento experimental, os efeitos das variáveis não foram significativos, exceto para a secção intestinal. Os resultados de coeficiente de permeabilidade aparente (Papp) obtidos foram de 0,09 x 10-4 cm/s para lamivudina e de 0,22 x 10-4 cm/s para o metoprolol. O valor de Papp obtido de para o metoprolol é próximo dos valores encontrados na literatura para outras técnicas. Para a lamivudina, entretanto, a diferença encontrada em comparação às células Caco-2 pode ser devida às diferentes técnicas empregadas. / This work aimed to propose a new method for studying drug permeability using frog intestinal epithelium (Rana catesbeiana) in ex vivo method, using Franz cells. By using intestinal epithelium, a disposal material from an animal used as human food, can be considered an alternative method, because it doesn\'t involve the sacrifice of animals. The amount of permeated drug was determined by capillary electrophoresis method with UV detection and validated for antiviral drugs lamivudine, zidovudine and acyclovir in the presence of metoprolol and floridizina. The drug chosen as a model in permeability studies was lamivudine. To establish the experimental protocol for the permeability studies, a three-way analysis of variance was proposed to check the influence of intestinal section, pH of Ringer\'s solution and the temperature on the permeability. Total amount of drug permeated (Qt), apparent permeability coefficient (Papp) and first-order constant absorption (ka) were determined. By the analysis of experimental design, the effects of the variables were not significant, except for intestinal section. The results of apparent permeability coefficient (Papp) obtained were 0.09 x 10-4 cm/s for lamivudine and 0.22 x 10-4 cm/s for metoprolol. The value of Papp obtained for metoprolol is quite close to the values found in literature for other methods. For lamivudine, however, the difference found in comparison to Caco-2 cells may be due to different techniques.

O objetivo deste estudo foi avaliar os efeitos da suplementação de Zn (na forma de ZnO nanoparticulado) em dietas para leitões recém-desmamados sobre o desempenho, a ocorrência de diarreia, a digestibilidade dos nutrientes, a excreção de Zn nas fezes, os parâmetros sanguíneos, a histologia do epitélio intestinal, a morfometria de órgãos e a contagem bacteriana no conteúdo intestinal em comparação ao uso de dose farmacológica de Zn (na forma de ZnO). Foram utilizados 192 leitões desmamados aos 21 dias, em um experimento em blocos casualizados, com 6 tratamentos, 8 repetições (blocos) e 4 animais por unidade experimental (baia). Os tratamentos foram: controle negativo - dieta basal com 100 mg de Zn/kg de ração (na forma de ZnO); controle positivo - dieta basal com 2400 mg de Zn/kg de ração (na forma de ZnO), e dieta basal com 12, 24, 48 ou 96 mg de Zn/kg de ração (na forma de ZnO-N). Os leitões foram alimentados com as dietas experimentais, durante os primeiros 21 dias de experimento. Dos 22 aos 35 dias, todos os animais foram alimentados com uma única dieta, com níveis basais de Zn. A ocorrência de diarreia foi registrada diariamente. Amostras de fezes foram coletadas para determinação da digestibilidade dos nutrientes da dieta e quantificação do Zn excretado. Amostras de sangue foram coletadas no 19° dia do experimento para análise dos parâmetros sanguíneos. No 21º dia, um animal de cada baia foi abatido para a realização da morfometria dos órgãos, histologia do epitélio intestinal e contagem bacteriana. Os dados foram submetidos à análise de variância e à regressão polinomial. Contrastes ortogonais foram utilizados para comparar o tratamento controle positivo com cada um dos níveis de Zn (na forma de ZnO-N). Não foram observados efeitos dos níveis de Zn (ZnO-N) sobre o desempenho, a excreção de Zn nas fezes, o hemograma, a morfometria de órgãos, a histologia do epitélio intestinal e a contagem bacteriana no conteúdo intestinal. O aumento dos níveis de Zn (ZnO-N) aumentou linearmente a digestibilidade aparente dos nutrientes da dieta. Foi observado efeito quadrático dos níveis de Zn (ZnO-N) sobre a frequência da ocorrência de diarreia entre os dias 1 e 7 e sobre a concentração plasmática de Zn. No período de 1 a 21 dias foi observado um menor consumo diário de ração para os níveis de Zn (ZnO-N) em comparação ao controle positivo. Não foram observados diferenças entre o controle positivo e os níveis de Zn (ZnO-N) para as variáveis de desempenho e a frequência da ocorrência de diarreia durante o período de 21 a 35 dias. Foi observada uma menor excreção de Zn nas fezes, e uma menor concentração plasmática de Zn para os níveis de Zn (ZnO-N) em comparação ao controle positivo. A suplementação de Zn, na forma de ZnO-N, não foi capaz de substituir a dose farmacológica de Zn (ZnO) no controle da diarreia após o desmame. Os níveis de Zn, na forma de ZnO-N, não ocasionaram toxicidade nos animais e propiciaram uma redução na excreção de Zn nas fezes. / The purpose of this study was to evaluate the effects of dietary Zn (as ZnO nanoparticles) on performance, diarrhea occurrence, nutrient digestibility, Zn excretion in the feces, blood parameters, histology of gut epithelium, organs morphometry and intestinal bacterial count of weanling pigs compared to the use of pharmacological doses of Zn (as ZnO). One hundred and ninety-two 21d-weaned pigs (5.90±0.83 kg BW) were used in a randomized complete block design experiment with 6 treatments, 8 replications per treatment, and 4 animals per experimental unit (pen). The treatments were: negative control (NC): basal diet (based on corn, soybean meal, dried whey and dried plasma) with 100 mg Zn (as ZnO)/kg diet; positive control (PC): basal diet with 2,400 mg Zn(as conventional ZnO, 150nm)/kg diet and basal diet with 12, 24, 48 or 96 mg Zn (as ZnO-N, 70nm)/kg diet. Pigs were fed dietary treatments from 1 to 21 d feeding period followed by a common diet (same diet for all treatments) from 22 to 35 d feeding period. Diarrhea occurrence was recorded daily. Feces samples were collected to determine the digestibility of the diet and to quantify the Zn excreted. Blood samples were collected on the 19th day of the experiment for analysis of blood parameters. On the 21th day one pig per pen was slaughtered for the analyses of organs morphometry, intestinal epithelium histology and bacterial count. ANOVA and polynomial regression analysis (for levels of Zn as ZnO-N) were performed. Orthogonal contrasts were used to compare positive control with each level of Zn (as ZnO-N). No effects of Zn levels (as ZnO-N) were observed on performance, Zn excretion on feces, blood count, organs morphometry, intestinal epithelium histology and intestinal bacterial count. Increased levels of Zn (as ZnO-N) linearly increased the apparent digestibility of nutrients. It was observed a quadratic effect of Zn levels (as ZnO-N) on the frequency of diarrhea occurrence between 1 and 7 d and on the Zn plasma concentration. From 1 to 21 d of experimental period, lower daily feed intake for Zn levels (as ZnO-N) was observed compared to positive control. No differences were observed among the positive control and levels of Zn (as ZnO-N) for performance and diarrhea occurrence during the period 21 to 35 d. Lower Zn excretion in feces and lower Zn plasma concentration were observed for Zn levels (as ZnO-N) compared to the positive control. Zn supplementation, as ZnO-N, could not to replace the pharmacological dose of Zn (ZnO) to control diarrhea after weaning. The levels of Zn, as ZnO-N, did not cause toxicity of weanling pigs and reduced Zn excretion in the feces.

Les particules de dioxyde de titane (TiO2) sont utilisées dans de nombreux secteurs industriels du fait de leurs propriétés physiques et chimiques intéressantes. Depuis une dizaine d’années, elles sont également utilisées sous forme nanoparticulaire car la taille nanométrique leur apporte de nouvelles propriétés, recherchées dans certaines applications industrielles. Elles sont par exemple utilisées comme colorant blanc dans le secteur de la cosmétologie, de la pharmacologie et dans les industries agroalimentaires. Dans ces dernières, l’utilisation de ces particules est autorisée car le TiO2 est un composé insoluble et relativement inerte. Le colorant alimentaire E171, autorisé depuis 1966, est ainsi constitué de particules de TiO2, initialement sous forme micrométrique, mais il s’avère que selon les procédés de fabrication, entre 10 et 43 % (selon les études) de ces particules présentent un diamètre inférieur à 100 nm, i.e. sont sous forme nanométrique. Ce n’est pas un nanomatériau du point de vue de la définition européenne, il n’est donc pas soumis à l’obligation d’étiquetage dans les produits alimentaires. Le E171 est présent dans de nombreux aliments sans que son impact sur la santé humaine, après ingestion, n’ait été clairement documenté. De plus en plus d’études s’intéressent à la toxicité des nanoparticules (NPs) après leur ingestion, mais peu d’entre elles ont été menées avec le E171 à proprement parler. Les études in vivo et in vitro publiées à ce jour démontrent que les NPs de TiO2 sont peu toxiques. Leur absorption intestinale et leur translocation vers le système sanguin puis des organes secondaires est faible. Les principaux effets décrits sont une augmentation des espèces réactives de l’oxygène associées à un stress oxydant, l’induction de marqueurs de l’inflammation, et plus récemment l’induction du stress du réticulum endoplasmique. Des effets sont également rapportés sur différents paramètres de la barrière intestinale, i.e. le microbiote, le mucus, les transporteurs membranaires, les jonctions cellulaires et l’immunité intestinale. Chez certaines personnes, cette barrière est compromise, elles sont donc potentiellement plus sensibles aux micros et nanos-particules contenues dans l’alimentation. Leur épithélium intestinal est enflammé, et à long terme, ces personnes peuvent développer des maladies inflammatoires chroniques de l’intestin et dans les cas les plus graves, des cancers.L’objectif de cette thèse est d’étudier la toxicité du colorant alimentaire E171 et d’approfondir les connaissances relatives à l’impact des NPs de TiO2 sur le système gastro-intestinal. Pour cela, nous avons travaillé avec différents modèles cellulaires d’épithélia intestinaux humain, un modèle d’épithélium jointif composé d’entérocytes Caco-2, un modèle d’épithélium sécrétant une couche de mucus, composé de cellules Caco-2 et HT29-MTX et enfin un modèle d’épithélium bordant les plaques de Peyer, composé des cellules Caco-2(C1) et RajiB. Ces modèles cellulaires ont été exposés de façon aigüe (6 h, 24 h et 48 h) ou chronique (21 jours), au colorant E171 ainsi qu’à deux NPs de TiO2 : A12, qui a la même structure cristalline que le E171 et P25, une NP très documentée dans la littérature. Nos résultats montrent que le E171 et les NPs de TiO2 sont modérément toxiques, ils n’engendrent pas de mortalité cellulaire ni de dommages à L’ADN. Néanmoins, ils provoquent une accumulation d’espèces réactives de l’oxygène intracellulaires et modulent certains marqueurs impliqués dans le stress oxydant, le stress du réticulum endoplasmique et l’inflammation. Ils impactent également la sécrétion et la composition de la couche de mucus, l’expression des transporteurs ABC, qui sont des paramètres impliqués dans la fonction de barrière de l’épithélium intestinal, le rendant possiblement plus vulnérable aux agressions extérieures. / Micro-sized titanium dioxide (TiO2) particles are used for years by industrials for their attractive physical and chemical properties. The use of TiO2 nanoparticles (NPs) is also constantly increasing, because the nanometric size gives new interesting properties to particles which industrials are looking for. In some daily-life products including paints, plastics, paper, medicines and food, micro-sized TiO2 particles are used as a pigment for their opacifying and whitening capacities. The use of TiO2 as a food additive, i.e. E171 in the EU, has been authorized in most countries since the 60ies, without any established acceptable daily intake, because of their low toxicity and intestinal absorption. However, it was recently shown that E171 can contain up to 43% of particles with diameter ranging from 1 to 100 nm, i.e. NPs. Still, E171 is not a nanomaterial as described in the European recommendation of definition because it contains less than 50% of NPs (in number). Food grade TiO2 is present in a wide range of food products while little is known about its toxicological impact to human health. The toxicity of ingested TiO2, either nano- or micro-sized, is increasingly documented, still E171 itself is rarely used in these studies.According to in vivo and in vitro studies, TiO2 particles were proven relatively safe for intestinal cells, no cytotoxicity neither genotoxicity were reported. Nevertheless, particles were often reported to increase reactive oxygen species (ROS) cell content, to impair autophagic processes and modulate gene expression and the content of proteins involved in oxidative stress, endoplasmic reticulum stress and inflammatory response regulation. Interestingly, their reported impact on intestinal cells suggests alteration of almost all the components of the intestinal barrier function, i.e. microbiota, mucus, cell junctions and transporters. This intestinal barrier function is altered in patients suffering from intestinal bowel diseases, these persons are thus possibly more sensitive to mineral particulate in food.The present study aimed at improving knowledge on the toxicity of food-grade TiO2. To this purpose, the impact of E171 was evaluated on in vitro cell models representative of the human intestinal epithelium, i.e. a model of differentiated Caco-2 enterocytes, a model of mucus-secreting epithelium obtained by coculture of Caco-2 and HT29-MTX mucus-secreting cells and a model of the follicle-associated epithelium, which lines Peyer patches, obtained by coculture of Caco-2(C1) and RajiB cells. These cell models were either acutely exposed for 6 h, 24 h and 48 h or chronically exposed for 21 days to E171. In parallel, they were exposed to two model TiO2-NPs, A12 which has the same crystalline structure as E171 and P25, a well-documented TiO2-NPs. Our results show that E171 and TiO2-NPs induced no overt cell mortality but significant oxidative stress, and that they oxidatively damage DNA. They modulate the expression of genes involved in oxidative stress and endoplasmic reticulum stress regulation. They also modulate the expression of genes, as well as the content of proteins from mucus, ABC transporters and inflammatory markers, which are the main players of the intestinal barrier function and presumably increase epithelium sensitivity to xenobiotics. These data suggest that they may be implicated in the development or aggravation of inflammatory bowel diseases.